PF4 and head and neck cancer: Further comprehensive investigations on larger patient cohorts in correlation with the specific individual therapy regimen and therapy response will help to further elucidate the meaningfulness of plasma-derived exosomes and chemokine CXCL4 as potential bioliquid indicators in head and neck cancer.